PBMares Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$525K Hold
687
0.09% 111
2025
Q2
$536K Buy
687
+73
+12% +$56.7K 0.1% 102
2025
Q1
$507K Buy
614
+14
+2% +$11.6K 0.1% 109
2024
Q4
$463K Buy
600
+107
+22% +$88.6K 0.09% 115
2024
Q3
$437K Buy
493
+43
+10% +$38.7K 0.09% 118
2024
Q2
$407K Sell
450
-32
-7% -$25.6K 0.1% 118
2024
Q1
$375K Sell
482
-742
-61% -$528K 0.1% 125
2023
Q4
$713K Hold
1,224
0.21% 75
2023
Q3
$657K Hold
1,224
0.24% 76
2023
Q2
$574K Hold
1,224
0.21% 86
2023
Q1
$420K Hold
1,224
0.16% 111
2022
Q4
$448K Sell
1,224
-408
-25% -$145K 0.18% 96
2022
Q3
$528K Sell
1,632
-202
-11% -$64K 0.23% 84
2022
Q2
$595K Hold
1,834
0.26% 71
2022
Q1
$525K Sell
1,834
-55
-3% -$14.2K 0.32% 85
2021
Q4
$522K Hold
1,889
0.22% 89
2021
Q3
$436K Buy
1,889
+199
+12% +$49.1K 0.21% 94
2021
Q2
$388K Hold
1,690
0.21% 101
2021
Q1
$316K Buy
1,690
+8
+0.5% +$1.56K 0.26% 106
2020
Q4
$284K Buy
+1,682
New +$251K 0.33% 95
2020
Q3
Sell
-1,282
Closed -$210K 113
2020
Q2
$210K Buy
+1,282
New +$197K 0.32% 101

Other funds holding LLY

PBMares Wealth Management's LLY Position: Q3 2025 in Review

PBMares Wealth Management held its Eli Lilly (LLY) position steady in Q3 2025 at 687 shares worth $525K. The position accounts for 0.09% of the portfolio, ranked #111.

PBMares Wealth Management first reported a position in LLY in Q2 2020 and has held it in 21 quarters since. The position peaked at $713K in Q4 2023. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • PBMares Wealth Management held 687 shares of Eli Lilly worth $525K as of Q3 2025.
  • PBMares Wealth Management left its Eli Lilly share count unchanged in Q3 2025.
  • Eli Lilly made up 0.09% of PBMares Wealth Management's portfolio in Q3 2025, its #111 holding.
  • PBMares Wealth Management first reported a position in Eli Lilly in Q2 2020 and has held it in 21 quarters since.
  • PBMares Wealth Management's Eli Lilly position peaked at $713K in Q4 2023.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on PBMares Wealth Management's 13F filing for Q3 2025, filed 27 Oct 2025.